Eprenetapopt combined with venetoclax and azacitidine in TP53-mutated acute myeloid leukaemia: a phase 1, dose-finding and expansion study

Guillermo Garcia-Manero, Aaron D. Goldberg, Eric S. Winer, Jessica K. Altman, Amir T. Fathi, Olatoyosi Odenike, Gail J. Roboz, Kendra Sweet, Crystal Miller, Anders Wennborg, Denice K. Hickman, Rashmi Kanagal-Shamanna, Hagop Kantarjian, Jeffrey Lancet, Rami Komrokji, Eyal C. Attar, David A. Sallman

Research output: Contribution to journal › Article › peer-review

22 Scopus citations

Fingerprint

Dive into the research topics of 'Eprenetapopt combined with venetoclax and azacitidine in TP53-mutated acute myeloid leukaemia: a phase 1, dose-finding and expansion study'. Together they form a unique fingerprint.

Medicine & Life Sciences